Predictive factors of metabolic changes after interferon-free treatment in hepatitis C infected patients

Predictive factors of metabolic changes after interferon-free treatment in hepatitis C infected patients

Chronic hepatits C virus (HCV) infection is a systemic infection with multiple extrahepatic manifestations, including alterations in lipid and glucose metabolism. Interferon-free treatment reverses metabolic abnormalities through virus eradication, but is associated with significant elevation in ser...

Full description

Bibliographic Details
Main Authors:	Ioana Hunea, Larisa Miftode, Olivia Dorneanu, Claudia-Elena Plesca, Daniela Leca, Tudorița-Gabriela Parânga, Liliana Vlad, Egidia-Gabriela Miftode
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2020-03-01
Series:	Romanian Journal of Infectious Diseases
Subjects:	interferon free treatment hepatic steatosis nafld
Online Access:	https://rjid.com.ro/articles/2020.1/RJID_2020_1_EN_Art-03.pdf

Similar Items

Factori predictivi ai modificărilor metabolice asociate tratamentului interferon-free la pacienţi cu hepatită cronică virală tip C
by: Ioana Hunea, et al.
Published: (2020-03-01)

THE IMPORTANCE OF CLINICAL PICTURE IN THE DIAGNOSIS OF GUILLAIN-BARRÉ SYNDROME
by: Tudorita-Gabriela Paranga, et al.
Published: (2019-12-01)

IMPORTANȚA TABLOULUI CLINIC ÎN DIAGNOSTICUL SINDROMULUI GUILLAIN-BARRÉ
by: Tudorița-Gabriela Părângă, et al.
Published: (2019-12-01)

Diabetes Mellitus—A Risk Factor for Unfavourable Outcome in COVID-19 Patients—The Experience of an Infectious Diseases Regional Hospital
by: Egidia Miftode, et al.
Published: (2021-06-01)

Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants
by: Tudorita Gabriela Paranga, et al.
Published: (2023-06-01)

Deep-learning-based hepatic fat assessment (DeHFt) on non-contrast chest CT and its association with disease severity in COVID-19 infections: A multi-site retrospective studyResearch in context
by: Gourav Modanwal, et al.
Published: (2022-11-01)

Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice
by: Gabriela V. Moreira, et al.
Published: (2022-11-01)

Diagnostic Performance of Ultrasound in Detecting Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease Considering MRI Proton Density Fat Fraction as the Reference Standard
by: Ankita Aggarwal, et al.
Published: (2024-01-01)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
by: Zhengyu Hu, et al.
Published: (2022-09-01)

Investigating Histological Changes and Gene Expression of Interleukin-8, Interleukin-12, and Interferon Beta in Liver Tissue After Consumption of Lactobacillus rhamnosus GG Probiotic in Steatosis Model Rats
by: F Rostamkhani
Published: (2022-08-01)

Investigating Histological Changes and Gene Expression of Interleukin-8, Interleukin-12, and Interferon Beta in Liver Tissue After Consumption of Lactobacillus rhamnosus GG Probiotic in Steatosis Model Rats
by: F Rostamkhani
Published: (2022-08-01)

The relationship between NAFLD with diet and exercise: Current perspectives
by: Fariba Aghaei
Published: (2022-12-01)

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
by: Tieshan Teng, et al.
Published: (2022-07-01)

Protective Effects of Gnetin C from Melinjo Seed Extract against High-Fat Diet-Induced Hepatic Steatosis and Liver Fibrosis in NAFLD Mice Model
by: Tohfa Kabir, et al.
Published: (2023-09-01)

Using synbiotics supplementation to treat hepatic steatosis: A comprehensive meta-analysis of randomized controlled trials
by: Ammar Nojaid, et al.
Published: (2023-06-01)

Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis
by: Laura De Rosa, et al.
Published: (2022-02-01)

The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments
by: Phumelele Yvonne Siphepho, et al.
Published: (2021-10-01)

Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
by: Jinyun Bai, et al.
Published: (2020-07-01)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
Published: (2006-04-01)

The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy
by: Fabio Mesquita, et al.
Published: (2016-11-01)

Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice
by: Sergio Quesada-Vázquez, et al.
Published: (2021-10-01)

Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with <i>Clostridioides difficile</i>: Single-Center Study from NE Romania during the COVID-19 Pandemic
by: Lidia Oana Stămăteanu, et al.
Published: (2023-06-01)

The Clash of the Titans: COVID-19, Carbapenem-Resistant <i>Enterobacterales,</i> and First <i>mcr-1</i>-Mediated Colistin Resistance in Humans in Romania
by: Ionela-Larisa Miftode, et al.
Published: (2023-02-01)

Early transcriptome changes associated with western diet induced NASH in Ldlr−/− mice points to activation of hepatic macrophages and an acute phase response
by: Jyothi Padiadpu, et al.
Published: (2023-08-01)

Amelioration of Hepatic Steatosis by the Androgen Receptor Inhibitor EPI-001 in Mice and Human Hepatic Cells Is Associated with the Inhibition of CYP2E1
by: Shuqin Wang, et al.
Published: (2022-12-01)

HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling
by: Xiaofang Zhang, et al.
Published: (2020-11-01)

Association between weight-adjusted-waist index with hepatic steatosis and liver fibrosis: a nationally representative cross-sectional study from NHANES 2017 to 2020
by: Yun Shen, et al.
Published: (2023-05-01)

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
by: Annika Riemann, et al.
Published: (2022-07-01)

Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis
by: Chiara Spiezia, et al.
Published: (2023-05-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018
by: Jingli Wen, et al.
Published: (2023-12-01)

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
by: Shan Li, et al.
Published: (2018-06-01)

Association between SII and hepatic steatosis and liver fibrosis: A population-based study
by: Ruijie Xie, et al.
Published: (2022-09-01)

Nicotinamide and NAFLD: Is There Nothing New Under the Sun?
by: Maria Guarino, et al.
Published: (2019-09-01)

Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection Neumonitis intersticial secundaria a tratamiento con interferón pegilado
by: J. Torres Macho, et al.
Published: (2010-10-01)

INFECTIOUS ENDOCARDITIS WITH COXIELLA BURNETII
by: Claudia-Elena Plesca, et al.
Published: (2017-12-01)

Association of family income to poverty ratio and vibration-controlled transient elastography quantified degree of hepatic steatosis in U.S. adolescents
by: Meiling Tang, et al.
Published: (2023-03-01)

INTERFERON-FREE THERAPY FOR HEPATITIS C IN PAKISTAN
by: Dure Nayab, et al.
Published: (2017-03-01)

A case of autoimmune hepatitis following pegylated interferon treatment of chronic hepatitis delta
by: Feruze Enc, et al.
Published: (2020-08-01)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-07-01)